Although the belimumab, a biologic drug for the blockade of BAFF, has been shown to inhibit the survival of autoreactive B cells in SLE [145], we found that low-dose BAFF treatment induced the generation of IL-10-secreting Bregs both in vitro and in vivo. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.